Nitroflurbiprofen is primarily utilized in the field of medical research due to its anti-inflammatory and analgesic properties. It is often studied for its potential to reduce inflammation and pain in various conditions, particularly in the context of neurodegenerative diseases. Researchers are particularly interested in its ability to inhibit cyclooxygenase enzymes, which play a key role in the inflammatory process. This makes it a candidate for developing treatments for conditions like Alzheimer's disease, where inflammation is a contributing factor. Additionally, its nitro group is believed to enhance its pharmacological activity, making it a subject of interest in the development of new therapeutic agents.